Eli Lilly Alzheimer's drug setback extends rival Biogen's lead – analysts
(Reuters) - The U.S. health regulator's rejection of accelerated approval for Eli Lilly and Co's Alzheimer's disease drug extends the market lead for ...
Stay updated with breaking news from Andrew Baum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
(Reuters) - The U.S. health regulator's rejection of accelerated approval for Eli Lilly and Co's Alzheimer's disease drug extends the market lead for ...
A Douglas County judge did not follow state law during divorce proceedings when he placed restrictions on a father's ability to travel abroad with his children, Colorado's second-highest court decided
The global diabetes market is segmented based on the type, drug class, and devices used to treat the condition.
Although Amber A. Threlkel's lawyer alleged one juror was "sleeping throughout a significant portion of my closing argument" at Threlkel's 2019 trial, District Court Judge Andrew Baum responded that he
In 2023, digitalization will increase in the biotech industry as the possibility of online and remote assessment, diagnosis, and treatment of patients around the world heightens.